Deregulation of IL-37 and its miRNAs modulators in sarcopenic patients after rehabilitation

Table 1. Epidemiological and clinical characterization of the patients enrolled in the study

Sarcopenic patients	T₀	T₁	p-value
N°	21	21
Gender (M:F)	8:13	–
Age (years)	73.2 ± 8.9	–
Education (years)	8.2 ± 3.13	–
MMSE	28.8 ± 1.13	28.5 ± 2.27	–
CDT	3.40 ± 1.51	4.19 ± 0.84	0.0026
Yesavage GDS	8.14 ± 5.67	7.34 ± 5.85	0.04
CCI	3.61 ± 1.41	–	–
KATZ	2.88 ± 1.31	5.33 ± 0.67	0.0001
I.A.D.L (LAWTON-Brody instrumental activity)	2.89 ± 0.32	3.44 ± 1.05	0,0084

Data are expressed as mean ± standard deviation
Statistical analysis were performed using Wilcoxon test (paired samples); p-value (p) < 0.05 were considered statistically significant
MMSE: Mini-Mental State Examination; CDT: Clock Drawing test; GDS: Geriatric Depression Scale; CCI: Charlson Comorbidity Index

ISSN: 1479-5876